Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis

In a phase III controlled trial IMproved Protection Against Cytomegalovirus in Transplantation (IMPACT) comparing 200 with 100 days of valganciclovir prophylaxis in 318 cytomegalovirus D+/R- kidney transplant recipients, an equal number of patients (n=3 per arm) had known ganciclovir resistance muta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2010-12, Vol.90 (12), p.1409-1413
Hauptverfasser:	SUNWEN CHOU, MAROUSEK, Gail, BOIVIN, Guy, GOYETTE, Nathalie, FARHAN, Mahdi, IVES, Jane A. L, ELSTON, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Base Sequence Biological and medical sciences Cytomegalovirus Cytomegalovirus - drug effects Cytomegalovirus - genetics Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - genetics Follow-Up Studies Fundamental and applied biological sciences. Psychology Fundamental immunology Ganciclovir - analogs & derivatives Ganciclovir - therapeutic use Genetic Predisposition to Disease Genetic Variation Humans Infectious diseases Medical sciences Phenotype Polymorphism, Single Nucleotide Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Time Factors Tissue, organ and graft immunology Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!